Erol R. Akdamar - 30 Jan 2023 Form 4 Insider Report for HCA Healthcare, Inc. (HCA)

Role
Group President
Signature
/s/ Kevin A. Ball, Attorney-in-Fact
Issuer symbol
HCA
Transactions as of
30 Jan 2023
Net transactions value
$0
Form type
4
Filing time
01 Feb 2023, 18:54:31 UTC
Previous filing
11 Jan 2023
Next filing
06 Feb 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HCA Stock Appreciation Right Award $0 +17,051 $0.000000 17,051 30 Jan 2023 Common Stock 17,051 $253.30 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock appreciation rights vest in four equal annual installments beginning on January 30, 2024.